Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3455-61. doi: 10.1167/iovs.09-4386. Epub 2010 Feb 24.
PURPOSE. The goal of this study was to determine the molecular mechanism by which transforming growth factor-alpha (TGF-alpha) is a more potent activator of epidermal growth factor receptor (EGFR)-mediated corneal wound healing than epidermal growth factor (EGF). METHODS. Telomerase immortalized human corneal epithelial (hTCEpi) cells and primary human corneal epithelial cells were tested for their ability to migrate in response to EGF and TGF-alpha. In parallel, the endocytic trafficking of the EGFR in response to these same ligands was examined using indirect immunofluorescence, immunoblots, and radioligand binding. RESULTS. TGF-alpha, compared with EGF, is a more potent activator of corneal epithelial cell migration. Although both TGF-alpha and EGF were able to induce EGFR internalization and phosphorylation, only those receptors that were stimulated with EGF progressed to lysosomal degradation. EGFRs stimulated with TGF-alpha recycled back to the plasma membrane, where they could be reactivated with ligand. CONCLUSIONS. This study reveals that EGFR-mediated cell migration is limited by ligand-stimulated downregulation of the EGFR. This limitation can be overcome by treating cells with TGF-alpha because TGF-alpha stimulates EGFR endocytosis, but not degradation. After internalization of the TGF-alpha/EGFR complex, EGFR recycles back to the plasma membrane, where it can be restimulated. This sequence of events provides the receptor multiple opportunities for stimulation. Thus, stimulation with TGF-alpha prolongs EGFR signaling compared with EGF.
目的。本研究的目的是确定转化生长因子-α(TGF-α)作为表皮生长因子受体(EGFR)介导的角膜伤口愈合的更有效激活剂的分子机制,优于表皮生长因子(EGF)。
方法。端粒酶永生化人角膜上皮(hTCEpi)细胞和原代人角膜上皮细胞用于测试其对 EGF 和 TGF-α的迁移能力。同时,使用间接免疫荧光、免疫印迹和放射性配体结合法检查了这些相同配体对 EGFR 的内吞运输。
结果。与 EGF 相比,TGF-α是角膜上皮细胞迁移的更有效激活剂。尽管 TGF-α和 EGF 都能够诱导 EGFR 内化和磷酸化,但只有那些被 EGF 刺激的受体才能进展到溶酶体降解。用 TGF-α刺激的 EGFR 会返回到质膜,在那里可以用配体重新激活它们。
结论。本研究揭示了 EGFR 介导的细胞迁移受到配体刺激的 EGFR 下调的限制。通过用 TGF-α处理细胞可以克服这种限制,因为 TGF-α刺激 EGFR 内吞作用,但不刺激降解。TGF-α/EGFR 复合物内化后,EGFR 会返回到质膜,在那里可以被重新刺激。这一系列事件为受体提供了多次刺激的机会。因此,与 EGF 相比,TGF-α刺激延长了 EGFR 信号。